chr3-25598337-TTCTTCTTCATCAGAC-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_001330700.2(TOP2B):c.4836_4850delGTCTGATGAAGAAGA(p.Ser1613_Glu1617del) variant causes a disruptive inframe deletion change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
TOP2B
NM_001330700.2 disruptive_inframe_deletion
NM_001330700.2 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.47
Genes affected
TOP2B (HGNC:11990): (DNA topoisomerase II beta) This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, beta, is localized to chromosome 3 and the alpha form is localized to chromosome 17. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_001330700.2.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOP2B | NM_001330700.2 | c.4836_4850delGTCTGATGAAGAAGA | p.Ser1613_Glu1617del | disruptive_inframe_deletion | 36/36 | ENST00000264331.9 | NP_001317629.1 | |
TOP2B | NM_001068.3 | c.4821_4835delGTCTGATGAAGAAGA | p.Ser1608_Glu1612del | disruptive_inframe_deletion | 36/36 | NP_001059.2 | ||
TOP2B | XM_011534057.4 | c.4725_4739delGTCTGATGAAGAAGA | p.Ser1576_Glu1580del | disruptive_inframe_deletion | 35/35 | XP_011532359.1 | ||
TOP2B | XM_047448821.1 | c.4710_4724delGTCTGATGAAGAAGA | p.Ser1571_Glu1575del | disruptive_inframe_deletion | 35/35 | XP_047304777.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOP2B | ENST00000264331.9 | c.4836_4850delGTCTGATGAAGAAGA | p.Ser1613_Glu1617del | disruptive_inframe_deletion | 36/36 | 5 | NM_001330700.2 | ENSP00000264331.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 28, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with TOP2B-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant, c.4821_4835del, results in the deletion of 5 amino acid(s) of the TOP2B protein (p.Ser1608_Glu1612del), but otherwise preserves the integrity of the reading frame. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.